Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) has provided an announcement.
Shanghai MicroPort MedBot (Group) Co., Ltd. has established a Nomination Committee under its board of directors to enhance corporate governance and streamline the appointment process for directors and senior management. This move aims to optimize board composition and succession planning, ensuring that the company is well-positioned to address future challenges and opportunities.
The most recent analyst rating on (HK:2252) stock is a Sell with a HK$20.00 price target. To see the full list of analyst forecasts on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H stock, see the HK:2252 Stock Forecast page.
More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
Shanghai MicroPort MedBot (Group) Co., Ltd. is a joint stock company incorporated in China, focusing on the medical technology industry. The company is involved in the development of advanced medical robotics and related technologies.
Average Trading Volume: 5,962,532
Technical Sentiment Signal: Buy
Current Market Cap: HK$22.42B
See more insights into 2252 stock on TipRanks’ Stock Analysis page.